Virtual Library

Start Your Search

E. Smit

Moderator of

  • +

    Guiding the best targeted treatment (ID 27)

    • Event: ELCC 2018
    • Type: Multidisciplinary Tumour Board
    • Track:
    • Presentations: 3
    • Now Available
    • +

      Can we rely on liquid biopsy for treatment decision at the time of acquired resistance? (Now Available) (ID 109)

      14:45 - 15:15  |  Presenting Author(s): J. Remon-Masip

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

    • +

      EGFR activating mutation plus exon 20 co-mutation at baseline: Which TKI should we select for frontline treatment? (Now Available) (ID 110)

      15:15 - 15:45  |  Presenting Author(s): E. Smit

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

    • +

      Progression on osimertinib: When is it possible to continue with a targeted therapy? (Now Available) (ID 111)

      15:45 - 16:15  |  Presenting Author(s): D. Planchard

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • +

    Uncommon driver alterations: Should we use off-label targeted agents? (ID 10)

    • Event: ELCC 2018
    • Type: Controversy session
    • Track:
    • Presentations: 4
    • Now Available
    • +

      Follow guidelines of non-oncogene addicted NSCLC (Now Available) (ID 40)

      09:25 - 09:45  |  Presenting Author(s): F. Ciardiello

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

    • +

      Give an off-label prescription based on the best knowledge (Now Available) (ID 41)

      09:45 - 10:05  |  Presenting Author(s): J. Mazieres

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

    • +

      Introduction and first vote (Now Available) (ID 39)

      09:15 - 09:25  |  Presenting Author(s): E. Smit, F. Cappuzzo

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

    • +

      Second vote and conclusions (Now Available) (ID 42)

      10:05 - 10:15  |  Presenting Author(s): E. Smit, F. Cappuzzo

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.



Author of

  • +

    Guiding the best targeted treatment (ID 27)

    • Event: ELCC 2018
    • Type: Multidisciplinary Tumour Board
    • Track:
    • Presentations: 1
    • Now Available
    • +

      EGFR activating mutation plus exon 20 co-mutation at baseline: Which TKI should we select for frontline treatment? (Now Available) (ID 110)

      15:15 - 15:45  |  Presenting Author(s): E. Smit

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • +

    Next generation TKI: Frontline or later? (ID 22)

    • Event: ELCC 2018
    • Type: Controversy session
    • Track:
    • Presentations: 1
    • Now Available
    • +

      Later (Now Available) (ID 91)

      09:45 - 10:05  |  Presenting Author(s): E. Smit

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • +

    Uncommon driver alterations: Should we use off-label targeted agents? (ID 10)

    • Event: ELCC 2018
    • Type: Controversy session
    • Track:
    • Presentations: 2
    • Now Available
    • +

      Introduction and first vote (Now Available) (ID 39)

      09:15 - 09:25  |  Presenting Author(s): E. Smit

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

    • +

      Second vote and conclusions (Now Available) (ID 42)

      10:05 - 10:15  |  Presenting Author(s): E. Smit

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.